Premium
Effects of heparin on the vasodilator action of protamine in the rabbit mesenteric artery
Author(s) -
Akata Takashi,
Kodama Kenji,
Takahashi Shosuke
Publication year - 1993
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/j.1476-5381.1993.tb13756.x
Subject(s) - protamine , heparin , vasodilation , endothelium , protamine sulfate , chemistry , pharmacology , medicine , endocrinology , biochemistry
1 The effects of protamine on the rabbit isolated small mesenteric artery were investigated both in the presence and in the absence of heparin, by the isometric tension‐recording method. 2 The dissociation constant for the binding of heparin to protamine has never been previously reported, so in order to minimize the effects of protamine, known to have a vasodilator action, and to examine only the effects of a heparin‐protamine complex, the experiments with heparin were performed in the presence of high concentrations of heparin (21–700 u ml −1 ), concentrations at which heparin itself does not affect the vascular tone. 3 Protamine (15–500 μg ml −1 ), in the absence of heparin, was found to inhibit ( P < 0.05) noradrenaline (1 μ m )‐induced contractions both in endothelium‐intact and in endothelium‐denuded tissues. 4 Such vasodilator action of protamine in either endothelium‐intact or ‐denuded tissues continued, even in the presence of excess heparin at a heparin/protamine (H/P) ratio of 1.4 uμg −1 , but was almost completely blocked in the presence of a much greater excess of heparin (H/P ratio ≥ 4.7 u μg −1 ): heparin was present both before and during the application of protamine. 5 The vasodilator action of protamine in the absence of heparin was prolonged both in the endothelium‐intact and ‐denuded tissues after protamine had been washed out from the bath with Krebs solution. Although this washing out with a Krebs solution containing excess heparin (4.7 u ml −1 ) readily reversed such prolonged vasodilator action of protamine both in the endothelium‐denuded strips and in the endothelium‐intact strips which had been pretreated with inhibitors of the endothelium‐derived relaxing factor (EDRF) pathway, it did not affect the prolonged vasodilator action of protamine in the endothelium‐intact strips which received no pharmacological intervention. 6 These results suggest that: (1) only protamine, not a heparin‐protamine complex, exerts vasodilator action in vitro; (2) the vasodilator action of protamine presumably has an EDRF‐mediated component; and (3) protamine probably exerts its direct vasodilator action without entering the smooth muscle cell.